Why the study?
Heterogeneity and lack of data on immune mechanisms contributing to HF may partially underlie the failure of clinical trials targeting inflammatory mediators.
Cohort
Answers are grounded in this paper and cite their sources.
Heart failure, particularly HFpEF, is associated with a distinct pro-inflammatory immune cell profile and altered immune network architecture, highlighting specific systemic inflammatory mechanisms.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2022) conducted a cohort in Heart failure. Heart failure vs. Healthy controls was evaluated on Immune cell subsets and network architecture.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: